文献速递免疫规划

IgA缺陷小鼠对多糖疫苗的IgG抗体应答存在缺陷

Defective anti-polysaccharide IgG vaccine responses in IgA deficient mice.
PubMed 文献 · Vaccine · 2017-07-31

该研究在IgA缺陷小鼠中观察到针对多糖疫苗(土拉弗朗西斯菌LPS和Pneumovax)及多糖-蛋白结合疫苗(Prevnar和b型流感嗜血杆菌-破伤风类毒素疫苗)的IgG抗体应答存在特异性缺陷,而对蛋白疫苗Fluzone的应答正常;用活菌免疫可克服该缺陷,且与血清BAFF产生相关,作者认为这些发现可能对IgA缺陷患者的临床管理有参考意义。

要点

  • IgA缺陷小鼠对多糖疫苗及多糖-蛋白结合疫苗的IgG应答存在缺陷。
  • IgA缺陷小鼠对蛋白疫苗的IgG应答正常,且活菌免疫可克服多糖疫苗应答缺陷。
  • 活菌免疫可诱导血清BAFF产生,补充BAFF可增强IgA缺陷细胞体外多克隆IgG产生。

核心结论

  • IgA缺陷损害多糖抗原疫苗接种后的IgG类别转换,活菌免疫可克服该缺陷;作者认为这些发现可能对IgA缺陷患者的临床管理有参考意义。

研究设计与样本

  • 动物实验研究,比较IgA缺陷小鼠(IgA-/-)与野生型小鼠(IgA+/+)对不同疫苗的IgG抗体应答及活菌攻击后的保护效果。

主要发现

  • IgA-/-小鼠对土拉弗朗西斯菌LPS和Pneumovax等多糖疫苗的IgG抗体应答存在特异性缺陷,对Fluzone等蛋白疫苗的应答正常。
  • IgA-/-小鼠对Prevnar和b型流感嗜血杆菌-破伤风类毒素疫苗等多糖-蛋白结合疫苗的应答也存在缺陷。
  • 用蛋白疫苗免疫的IgA-/-小鼠可抵抗病原体攻击,而用多糖疫苗免疫的IgA-/-小鼠则不能抵抗。
  • 用活菌免疫后,IgA+/+与IgA-/-小鼠均能抵抗致死性攻击,且两者IgG抗多糖抗体应答相当。
  • 活菌免疫而非纯化多糖免疫可诱导血清B细胞活化因子(BAFF)产生;补充BAFF可增强IgA-/-细胞体外多克隆IgG产生。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We report that IgA-/- mice exhibit specific defects in IgG antibody responses to various polysaccharide vaccines (Francisella tularensis LPS and Pneumovax), but not protein vaccines such as Fluzone. This defect further included responses to polysaccharide-protein conjugate vaccines (Prevnar and Haemophilus influenzae type b-tetanus toxoid vaccine). In agreement with these findings, IgA-/- mice were protected from pathogen challenge with protein- but not polysaccharide-based vaccines. Interestingly, after immunization with live bacteria, IgA+/+ and IgA-/- mice were both resistant to lethal challenge and their IgG anti-polysaccharide antibody responses were comparable. Immunization with live bacteria, but not purified polysaccharide, induced production of serum B cell-activating factor (BAFF), a cytokine important for IgG class switching; supplementing IgA-/- cell cultures with BAFF enhanced in vitro polyclonal IgG production. Taken together, these findings show that IgA deficiency impairs IgG class switching following vaccination with polysaccharide antigens and that live bacterial immunization can overcome this defect. Since IgA deficient patients also often show defects in antibody responses following immunization with polysaccharide vaccines, our findings could have relevance to the clinical management of this population.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Furuya Y, Kirimanjeswara GS, Roberts S, et al. Defective anti-polysaccharide IgG vaccine responses in IgA deficient mice. Vaccine. 2017. PMID: 28774562. doi:10.1016/j.vaccine.2017.07.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。